View Exam | PowerPak

1. According to the US DHHS, which of the following combinations is recommended when ART should be started before HIV drug resistance and HLA-B*5701 results are available (e.g., in a person with acute HIV)?

A. Abacavir/dolutegravir/lamivudine B. Bictegravir/TAF/emtricitabine C. Dolutegravir/lamivudine D. Doravirine/lamivudine/TDF E. All are recommended

2. Which of the following combinations is currently preferred by the US DHHS HIV Treatment Guidelines for women throughout pregnancy?

A. Bictegravir/TAF/emtricitabine B. Dolutegravir/abacavir/lamivudine C. Doravirine + emtricitabine/TAF D. Doravirine/lamivudine/TDF E. All are preferred

3. Which regimen would require a dose adjustment when used in a transgender individual using gender-affirming hormone therapy?

A. Bictegravir/TAF/emtricitabine B. Darunavir/cobicistat/emtricitabine/TAF C. Dolutegravir/lamivudine D. Dolutegravir/abacavir/lamivudine

4. All of the below regimens are recommended by DHHS for people living with HIV who have had inconsistent engagement in care EXCEPT?

A. Bictegravir/TAF/emtricitabine B. Dolutegravir/abacavir/lamivudine C. Darunavir/cobicistat/emtricitabine/TAF D. Efavirenz/emtricitabine/TDF

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. According to the US DHHS, which of the following combinations is recommended when ART should be started before HIV drug resistance and HLA-B*5701 results are available (e.g., in a person with acute HIV)?

2. Which of the following combinations is currently preferred by the US DHHS HIV Treatment Guidelines for women throughout pregnancy?

3. Which regimen would require a dose adjustment when used in a transgender individual using gender-affirming hormone therapy?

4. All of the below regimens are recommended by DHHS for people living with HIV who have had inconsistent engagement in care EXCEPT?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. According to the US DHHS, which of the following combinations is recommended when ART should be started before HIV drug resistance and HLA-B*5701 results are available (e.g., in a person with acute HIV)?

2. Which of the following combinations is currently preferred by the US DHHS HIV Treatment Guidelines for women throughout pregnancy?

3. Which regimen would require a dose adjustment when used in a transgender individual using gender-affirming hormone therapy?

4. All of the below regimens are recommended by DHHS for people living with HIV who have had inconsistent engagement in care EXCEPT?

« Return to Activity

Customers who Purchased
this Activity also Purchased